Bac

General Information


DRACP ID  DRACP02051

Peptide Name   Bac

Sequence  RLCRIVVIRVCR

Sequence Length  12

UniProt ID  P22226  L8HPZ1 

PubChem CID  Not available

Origin  Bos taurus##Bos mutus

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
RAW 264.7 Mouse macrophage leukemia cell Leukemia <20% Killing=400 µg/ml MTT assay 2 days 1

Hemolytic Activity  Human erythrocytes: <10% Hemolysis=400 µg/ml

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antimicrobial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  DRACP02051

Helicity  Not available

Linear/Cyclic  Cyclic

Disulfide/Other Bond  Cys3<--->Cys11

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C63H120N24O13S2

Absent amino acids  ADEFGHKMNPQSTWY

Common amino acids  R

Mass  168231

Pl  12.02

Basic residues  4

Acidic residues  0

Hydrophobic residues  6

Net charge  4

Boman Index  -3024

Hydrophobicity  103.33

Aliphatic Index  170

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  125

Absorbance 280nm  11.36

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 23109411

Title  Linear bactenecin analogs with cell selectivity and anti-endotoxic activity

Doi 10.1002/psc.2460

Year  2012

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  DBAASPR_13529

DRACP is developed by Dr.Zheng's team.